risedronic acid has been researched along with 24,25-dihydroxyvitamin d 3 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Casado-Díaz, A; Dorado, G; Navarro-Valverde, C; Quesada-Gómez, JM; Santiago-Mora, R | 1 |
1 review(s) available for risedronic acid and 24,25-dihydroxyvitamin d 3
Article | Year |
---|---|
Stimulation of in-vitro angiogenesis by low concentrations of risedronate is mitigated by 1,25-dihydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
Topics: 24,25-Dihydroxyvitamin D 3; Animals; Bone Density Conservation Agents; Calcitriol; Etidronic Acid; Humans; In Vitro Techniques; Neovascularization, Physiologic; Risedronic Acid | 2015 |